# Anaemetro I.V. Infusion 500mg Drug Use Investigation

> **NCT03491228** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 107 (actual)

## Conditions studied

- Anaerobic Infection
- Infectious Enterocolitis
- Amebic Dysentery

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03491228
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2018-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03491228

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03491228, "Anaemetro I.V. Infusion 500mg Drug Use Investigation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03491228. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*